BioWorld

Dec. 8, 2005

View Archived Issues

ViroPharma Prices $150M Offer To Add To Capital, Pay Off Debt

ViroPharma Inc. is raising $150.7 million through a public offering to support business development activities and general corporate purposes, as well as to pay off a portion of the company's debt. (BioWorld Today) Read More

Antigenics Trims Work Force, Awaiting Results Of Phase III

Read More

Gene Therapy Firm Celladon Secures $30M Commitment

Read More

New MDD Report: Overview Of Cardiovascular Tech Sector

Read More

Other News To Note

Read More

U.S. Patent Disclosures

Read More